SILMEN-5

This brand name is authorized in Nigeria.

Active ingredients

The drug SILMEN-5 contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Meningococcal group A Polysaccharide (conjugated to TT) UNII `1I86B47NY4` - NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup A polysaccharide vaccine
`2`	Meningococcal group C Polysaccharide (conjugated to CRM197) UNII `9B7N7Y96MK` - NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CRM-197 ADIPIC ACID CONJUGATE
	Read more about Meningococcal serogroup C polysaccharide vaccine
`3`	Meningococcal group Y Polysaccharide (conjugated to CRM197) UNII `CBZ4BH7TJ1` - NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup Y polysaccharide vaccine
`4`	Meningococcal group W Polysaccharide (conjugated to CRM197) UNII `9F8QQ6EER1` - NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE ANTIGEN
	Read more about Meningococcal serogroup W135 polysaccharide vaccine
`5`	Meningococcal group X Polysaccharide (conjugated to TT)
	Read more about Meningococcal serogroup X polysaccharide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-100157	Injection	Silmen-5 INJ_PWD 0.5 mL 0.5 mL x 1's (in vial)	Freeze-dried formulated vaccine available in two presentations viz. 5-dose vial and single-dose vial. The freeze-dried vaccine is to be reconstituted with provided diluent i.e. 0.9% sodium chloride prior to the administration. 5-dose vial: The 5-dose vaccine vial is reconstituted with 2.5 mL of provided diluent i.e. 0.9% sodium chloride. Single-dose vial: The single-dose vaccine vial is reconstituted with 0.5 mL of provided diluent i.e. 0.9% sodium chloride Neither the vaccine nor the diluent contains any preservative	31/07/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07AH08	Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines
Discover more medicines within J07AH08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A6-100157

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.